Grace Therapeutics, Inc. · NASDAQ:GRCE
Nantahala Capital Management, LLC reported a 9.99% stake in Grace Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Nantahala Capital Management, LLC reported a 9.99% stake in Grace Therapeutics, Inc., 1,586,659 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 1,586,659
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 1,586,659 |
| Wilmot B. Harkey | 9.99% | 1,586,659 |
| Daniel Mack | 9.99% | 1,586,659 |
Source
Related
- Grace Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Grace Therapeutics, Inc. shareholders
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2025
- Schedule 13G · Nantahala Capital Management, LLC · May 15, 2025
- Form 4 · Opaleye Management Inc. · Oct 21, 2026
- Form 4 · Opaleye Management Inc. · Oct 16, 2026
- Form 4 · Opaleye Management Inc. · Oct 13, 2026
- Form 4 · Opaleye Management Inc. · Oct 5, 2026
- Form 4 · Opaleye Management Inc. · Oct 1, 2026